Physician profile
David H Mull
NPI 1104974641
$2,497.59
in general payments reported to CMS, 2019-2025
12 companies · $534 in 2025
The $534 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $25.74 · 2021: $35.98 · 2022: $79.31 · 2023: $547 · 2024: $865 · 2025: $534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,945.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $732.82 | 2023-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2) |
| Edwards Lifesciences Corporation | $649.35 | 2019-2025 | Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve, Konect Resilia |
| Abiomed | $380.30 | 2020-2025 | Impella |
| Boston Scientific Corporation | $251.16 | 2019 | |
| Baxter Healthcare | $129.50 | 2024-2025 | Preveleak, Perclot |
| Silk Road Medical, INC. | $125.00 | 2019 | |
| Ethicon US, LLC | $92.99 | 2020-2025 | Echelon; Endopath, Echelon Flex |
| Intuitive Surgical, INC. | $51.18 | 2024 | |
| Depuy Synthes Sales INC. | $33.60 | 2025 | Matrixrib |
| Midsouth Orthopedics INC. | $22.32 | 2024 | |
| Lemaitre Vascular, INC. | $17.10 | 2023 | Restoreflow |
| On Target Laboratories, INC | $12.27 | 2024 | Cytalux |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.